Rating History for Blueprint Medicines (BPMC) by Credit Suisse
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/31/2021 | Brad Canino | New Coverage | Neutral (N/A) |
100.00 (N/A) |
92.01 (92.29) |
0.3% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/31/2021 | Brad Canino | New Coverage | Neutral (N/A) |
100.00 (N/A) |
92.01 (92.29) |
0.3% | Details |
